MOLULOW

MSN to launch generic anti-COVID pill Molnupiravir under 'Molulow' brand

The group is all set to launch the generic Molnupiravir 200 mg capsules and it is being manufactured at its USFDA and MHRA accredited facility based out of Hyderabad, MSN Group said in a statement. Molulow will come as a pack of 4x10 capsule strips with each capsule in 200 mg strength.